Submacular Surgery

Indian Journal of Ophthalmology

Volumn 45, Issue 2, 1997, Pages 77-92

  Saxena, Sandeep ^a   Thomas, Matthew A ^a   Melberg, Nancy S ^a  

^a BARNES RETINA INSTITUTE   (United States)

Author keywords

Choroidal neovascularization; Submacular haemorrhage; Submacular surgery; Vitrectomy

Indexed keywords

CHOROID; HUMAN; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; RETINA DISEASE; RETINA MACULA LUTEA; REVIEW; SAFETY; TREATMENT OUTCOME; VASCULARIZATION; VITRECTOMY;

CHOROID; HUMANS; MACULA LUTEA; NEOVASCULARIZATION, PATHOLOGIC; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETINAL DISEASES; SAFETY; TREATMENT OUTCOME; VITRECTOMY;

EID: 0031151382     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (144)

1. Saxena S, Thomas MA, Melberg NS. Macular Surgery. In : Mieler WF. et al (eds) In Press.
2. Lopez PF, Grossniklaus HE, Lambert HM, et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 112: 647-656, 1991.
3. Grossniklaus HE, Martinez JA, Brown VB, et al. Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 114: 464-472, 1992.
4. Hotchkiss ML, Fine SL. Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 91: 177-183, 1981.
5. Hampton GR, Kohen D, Bird AC. Visual prognosis of disciform degeneration in myopia. Ophthalmology 90: 923-926, 1983.
6. Avila MP, Weiter JJ, Jalkh AE, et al. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91: 1573-1581, 1984.
7. Singerman LJ, Hatem G. Laser treatment of choroidal neovascular membranes in angioid streaks. Retina 1: 75-83, 1981.
8. Clarkson JG, Altman RD. Angioid streaks. Surv Ophthalmol. 26: 235-246, 1982;
9. Lim JI, Bressler NM, Marsh MJ, Bressler SB. Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 116: 414-423, 1993.
10. Klein R, Lewis RA, Myers SM, Myers FL. Subretinal neovascularization associated with fundus flavimaculatus. Arch Ophthalmol 96: 2054-2057, 1978.
11. Miller SA, Bresnick GH, Chandra SR. Choroidal neovascular membrane in Best's vitelliform macular dystrophy. Am J Ophthalmol 82: 252-255, 1976.
12. Callanan D, Gass JDM. Multifocal choroiditis and choroidal neovascularization associated with the multiple evanescent dot syndrome and acute idiopathic blind spot enlargement syndrome. Ophthalmology 99: 1678-1685, 1992.
13. Morgan CM, Schatz H. Recurrent multifocal choroiditis. Ophthalmology 93: 1138-1147, 1986.
14. Beebe WE, Kirkland C, Price J. A subretinal neovascular membrane as a complication of endogenous candida endophthalmitis. Ann Ophthalmol 19: 207-209, 1987.
15. Wysynski RE, Grossniklaus HE, Frank KE. Indirect choroidal rupture secondary to blunt ocular trauma : a review of eight eyes. Retina 8: 237-243,1988.
16. Ruby AJ, Jampol LM, Goldberg MF, et al. Choroidal neovascularization associated with choroidal hemangiomas. Arch Ophthalmol 110: 658-661, 1992.
17. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. III. Senile disciform macular degeneration. Am J Ophthalmol 63: 617-644, 1967.
18. Bressler SB, Bressler NM, Fine SL, et al. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol 93:157-163,1982.
19. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Arch Ophthalmol 111: 1200-1209,1993.
20. Oik RJ, Burgess DB, McCormick PA. Subfoveal and juxta foveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. Ophthalmology 91: 1592-1602, 1984.
21. Kleiner RC, Ratner CM, Enger C, Fine SL. Subfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history study. Retina 8: 225-229, 1988.
22. Campochiaro PA, Morgan KM, Conway BP, Stathos J. Spontaneous involution of subfoveal neovascularization. Am J Ophthalmol 109: 668-675, 1990.
23. Vander JF, Morgan CM, Schatz H. Growth rate of subretinal neovascularization in age related macular degeneration. Ophthalmology 96: 1422-1429, 1989.
24. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration : results of a randomized clinical trial. Arch Ophthalmol 100: 912-918, 1982.
25. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration : results of randomized clinical trial. Arch Ophthalmol 108: 816-824, 1990.
26. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy : three-year results from randomized clinical trials. Arch Ophthalmol 104: 694-701,1986.
27. Macular Photocoagulation Study Group. Argon laser photocoagulation for ocular histoplasmosis : results of a randomized clinical trial. Arch Ophthalmol 101: 1347-1357,1983.
28. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy : five year results from randomized clinical trials. Arch Ophthalmol 109: 1109-1114,1991.
29. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular vasculopathy. Arch Ophthalmol 104: 503-512, 1986.
30. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 108: 825-831,1990.
31. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Arch Ophthalmol 107: 344-352,1989.
32. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 109: 1232-1241,1991.
33. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration : guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 109:1242-1257,1991.
34. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 109:1220-1231, 1991.
35. Sorensen JA, Yanuzzi LA, Shakin JL. Recurrent subretinal neovascularization. Ophthalmology 92: 1059-1074,1985
36. Coscas G, Soubrane G, Ramahefasolo C, Fardeau C. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration : results of a randomized clinical trial. Arch Ophthalmol 109: 1258-1265,1991
37. Green WR. Clinicopathologic studies of treated choroidal neovascular membranes. A review and report of two cases. Retina 11: 328-356,1991
38. Fine SL, Wood WJ, Isernhagen RD. Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome : results of a pilot randomized clinical trial (letter). Arch Ophthalmol 111: 19-20,1993
39. de Juan E Jr, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 105:25-29,1988
40. Blinder KJ, Peyman GA, Paris CL, Gremillion CM Jr. Submacular scar excision in age-related macular degeneration. Int Ophthalmol 15:215-222,1991
41. Peyman GA, Blinder KJ, Paris CL, et al. A technique for retinal pigment epithelium transplantation for age related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg 22:102-108,1991
42. Thomas MA, Kaplan HJ. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol 111: 1-7,1991
43. Thomas MA. The use of vitreoretinal surgical techniques in subfoveal choroidal neovascularization. Curr Opin Ophthalmol 3: 349-356,1992
44. Thomas MA, Williams DF, Grand MG. Surgical removal of submacular hemorrhage and subfoveal choroidal neovascular membranes. Int Ophthalmol Clin 32: 173-188,1992
45. Ibanez HE, Thomas MA. Surgical approach to subfoveal neovascularization and submacular hemorrhage. Seminars in Ophthalmol 9: 56-64,1994
46. Ibanez HE, Thomas MA. Surgical excision of subfoveal choroidal neovascularization. Ophthalmol Clin North America 7: 51-57,1994
47. Thomas MA, Ibanez HE. Surgical excision of subfoveal neovascular membranes and subretinal strands. In : Tasman W, Jaeger EA (eds). Duane's Clinical Ophthalmology. Philadelphia, J.B. Lippincott Company, 1994, pp 1-10.
48. Thomas MA. Surgical removal of choroidal neovascular membranes. In: Ryan SJ (editor-in-chief) Retina Vol 3. 2nd Ed. St. Louis, Mosby, 1994, pp 2385-2393.
49. Thomas MA. Surgical removal of subfoveal choroidal neovascular membranes. In: Lewis H, Ryan SJ (eds). Medical and Surgical Retina : Advances, Controversies, and Management. St. Louis, Mosby, 1994, pp 63-81.
50. Thomas MA. Vitrectomy surgery for Subfoveal Choroidal Neovascularization and Submacular Hemorrhage. In: Bovino JA (ed) Macular Surgery, Connecticut, Appleton-Lange, 1994, pp 135-164.
51. Thomas MA, Lee CA, Pesin S, Lowe M. New instruments for submacular surgery. Am J Ophthalmol 112: 733-734, 1991.
52. Thomas MA, Ibanez HE. Instruments for submacular surgery. Retina 14: 84-87,1994.
53. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch ophthalmol 109:654-659, 1991.
54. Mein CE, Flynn HW. Recognition and removal of posterior cortical vitreous during vitreoretinal surgery for impending hole. Am J ophthalmol 111:611-613,1991.
55. Adelberg DA, Del Priore LV, Kaplan HJ. Surgery for subfoveal membranes in myopia, angioid streaks, and other disorders. Retina 15: 198-205,1995
56. Capone A Jr. Submacular surgical procedures. Int Ophthalmol Clin 1995; 35: 83-93.
57. Smiddy WE, Fine SL, Green WR, et al. Clinicopathologic correlation of krypton red, argon blue-green, and argon green photo coagulation in the human fundus. Retina 4: 15-21,1984.
58. Thomas EL, Apple DJ, Swartz M, et al. Histopathologic and ultrastructure of krypton and argon laser lesions in human retina-choroid. Retina 4: 22-39, 1984.
59. Eldrini AA, Ogden TE, Ryan SJ. Subretinal endophotocoagulation. A model of subretinal neovascularization in the rabbit. Retina 11: 244-247,1991.
60. Thomas MA, Ibanez HE. Subretinal endophotocoagulation in the treatment of choroidal neovascularization. Am J Ophthalmol 116: 279-285,1993.
61. Baron S, Tyring SK, Fleischmann WR Jr, et al. The interferons. Mechanisms of action and clinical applications. JAMA 266: 1375-1383,1991.
62. Spiegel RJ. Clinical overview of alpha Interferon. Studies and future directions. Cancer 59: 626,1987.
63. Volberding PA, Mitsuyasu RT, Golando JP, Spiegel RJ. Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A). Cancer 59 (suppl 3): 620,1987.
64. de Wit R, Schattenkerk JK, Boucher CA, et al. Clinical and virological effects of high-dosage recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma. Lancet 2: 1214,1988.
65. Brouty-Boye D, Zetter BR. Inhibition of cell motility by interferon. Science 208: 516-518,1980.
66. White CW, Wolf SJ, Korones DN, et al. Treatment of childhood angiomatous disease with recombinant interferon alpha-2a. J Pediatr 118: 59-66,1991.
67. Fung WE. Interferon alpha-2a for treatment of age-related macular degeneration (letter). Am J Ophthalmol 112: 349-50,1991.
68. Spiegel RJ. Dosage and toxicity. Alpha Interferon: dosage, toxicity and antibody formation. In: Silver HKB (ed). Interferons in cancer treatment: Biologic activity and clinical toxicity of interferons, clinical response to systemic interferons, alternate routes of administration. Missiaugo, Ont. MES Medical Education Services, 1986, pp 17-27.
69. Thomas MA, Ibanez HE Interferon alpha-2a in the treatment of subfoveal choroidal neovascularization. Am J Ophthalmol 115: 563-568,1993.
70. Chan CK, Kempin SJ, Noble SK, Palmer GA. The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study. Ophthalmology 101: 289-300,1994.
71. Collen D, Stassen JM, Marafino BJ, et al. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells. J Pharmacol Exp Ther 231: 146-152,1984.
72. Tiefenbaum AJ, Robison AK, Kurnik PB, et al. Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology. Circulation 71: 110-116,1985.
73. Thomas JW, Lopez PF, Lambert HM. Tissue plasminogen activator in the surgical excision of subfoveal choroidal neovascular membranes. Ophthalmic Surg 26: 374-376,1995.
74. Lambert HM, Capone A Jr, Aaberg TM, et al. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 115: 563-568,1993.
75. Thomas MA, Grand MG, Williams DF, et al. Surgical management of subfoveal choroidal neovascularization. Ophthalmology 99: 952-968,1992.
76. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal membranes: short-term post-operative results. Ophthalmology 99:969-972, 1992.
77. Thomas MA, Dickinson JD, Melberg NS, et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 101: 1384-1396, 1994.
78. Omerod LD, Puklin JE, Frank RN. Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration. Ophthalmology 101:1201-1210, 1994
79. O'Connor TB, Wolf MD, Arrindel EL, Mieler WF. Surgical removal of an extrafoveal fibrotic choroidal neovascular membrane with foveal serous detachment in age related macular degeneration. Retina 14: 125-129,1994
80. Gass JDM. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 118: 285-298,1994.
81. Brittis M, Lopez R, Gouras P, Kjeldbye H. Autotransplantation of cultured retinal pigment epithelium to Bruch's membrane in the rabbit eye. Transplantation proceedings 19: 1133-1139,1987.
82. Gouras P, Flood MT, Kjeldbye MK, et al. Transplantation of cultured human retinal pigment epithelium to Bruch's membrane of the owl monkey's eye. Curr Eye Res 4: 253-265,1985.
83. Gouras P, Flood MT, Kjeldbye MK. Transplantation of cultured human retinal cells to monkey retina. An Acad Brasil Cienc 56: 431-443,1984.
84. Gouras P, Brittis M, Lopez R, Brittis M, et al. Transplantation of retinal pigment epithelium prevents photoreceptor degeneration in the RCS rat. In La Vail M, Anderson RE, Holyfield JG (eds), Inherited and environmentally induced retinal degenerations, New York, Alan R. Liss, 1989, pp 659-671.
85. Gouras P, Lopez R. Transplantation of retinal epithelial cells. Invest Ophthalmol Vis Sci 30: 1681-1683,1989.
86. Lane C, Boulton M. Retinal pigment epithelium transplantation : technique and possible applications. Advances in the Biosciences 63: 125-138,1987.
87. Lane C, Boulton M, Bridgman A, Marshall J. Transplantation of retinal pigment epithelium in the miniature pig. Invest Ophthalmol Vis Sci 29 (suppl) : 405,1988
88. Lane C, Boulton M, Marshall J. Transplantation of retinal pigment epithelium using a pars plana approach. Eye 3: 27-32,1989.
89. Li L, Sheedlo HJ, Gaur V, Turner JE. Effects of macrophage and retinal pigment epithelial cell transplants on photoreceptor cell rescue in RCS rats. Curr Eye Res 10: 947-958,1991.
90. Li L, Sheedlo HJ, Turner JE. Long-term rescue of photoreceptor cells in the retinas of RCS dystrophic rats by RPE transplants. Progress in Brain Research 82: 179-185,1990.
91. Li L, Turner JE. Transplantation of retinal pigment epithelium cells to immature and adult rat hosts: short-and long-term survival characteristics. Exp Eye Res 47: 771-785,1988.
92. Li L, Turner JE, Inherited retinal dystrophy in the RCS rat : prevention of photoreceptor degeneration by pigment epithelial cell transplantation. Exp Eye Res 47: 911-917,1988.
93. Liu Y, Silverman MS, Berger AS, Kaplan HJ. Transplantation of confluent sheets of adult human RPE. Invest Ophthalmol Vis Sci 33 (suppl) : 1128,1992.
94. Lopez R, Gouras P, Britts M, Kjeldbye H. Transplantation of cultured rabbit retinal epithelium to rabbit retina using a closed-eye method. Invest Ophthalmol Vis Sci 28: 1131-1137,1987.
95. Lopez R, Gouras P, Kjeldbye H, et al. Transplanted retinal pigment epithelium modifies the retinal degeneration in the RCS rat. Invest Ophthalmol Vis Sci 33: 83-91,1992.
96. Seaton AD, Li L, Turner JE. RPE transplants stabilize retinal vasculature and prevent neovascularization in the RCS rat. Invest Ophthalmol Vis Sci 33: 83-91, 1992.
97. Sheedlo HJ, Li L, Turner JE. Functional and structural characteristics of photoreceptor cells rescued in RPE-cell grafted retinas of RCS dystrophic rats. Exp Eye Res 48: 841-854,1989.
98. Valentino TL, Kaplan HJ, Del Priore LV, et al. Retinal pigment epithelial repopulation in monkeys after submacular surgery. Arch Ophthalmol 113: 932-938,1995.
99. Del Priore LV, Hornbeck R, Kaplan HJ, et al. Surgical removal of retinal pigment epithelium causes atrophy of the choriocapillaris and outer retina. Invest Ophthalmol Vis Sci. 36 (suppl) : 1142,1995.
100. Del Priore LV, Russ Hornbeck, Kaplan HJ, et al. Debridement of the pig retinal pigment epithelium in vivo. Arch Ophthalmol 113: 939-944,1995.
101. Sarks SH, Van Driel D, Maxwell L, Killingsworth M. Softening of drusen and subfoveal neovascularization. Trans Ophthalmol Soc U.K. 100: 414-422,1980.
102. Green WR, Key SN III. Senile macular degeneration : a histopathologic study. Trans Am Ophthalmol Soc 75: 180-254,1977.
103. Friedman E, Smith TR, Kuwabara T. Senile choroidal vascular patterns and drusen. Arch Ophthalmol 69: 220-230,1963.
104. Desai VN, Del Priore LV, Pollack JS, Kaplan HJ. Choriocapillaris atrophy after submacular surgery in the presumed ocular histoplasmosis syndrome. Arch Ophthalmol 113: 409-410,1995.
105. Zarbin MA, Nasir M. Impaired choriocapillaris perfusion following subfoveal surgery for macular degeneration. Ophthalmology 100 (suppl) : 97,1993.
106. Pollack JS, Kaplan HJ, Del Priore LV, Smith MS. Choriocapillaris atrophy following subfoveal membrane excision in exudative age-related macular degeneration. Ophthalmology 100 (suppl) : 122,1993.
107. Nasir M, Zarbin MA. Choriocapillaris atrophy as a complication of surgical excision of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 34 (suppl) : 834,1993.
108. Pollack JS, Kaplan HJ, Del Priore LV, Smith MS. Choriocapillaris atrophy associated with exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 34 (suppl) : 834,1993.
109. Del Monte MA, Maumenee IH. New techniques for in vitro culture of human retinal pigment epithelium. Birth Defects 16: 327-338,1980.
110. Hay ED. In: Hay ED (ed) Cell Biology of Extracellular Matrix. New York, Plenum Press, 1981, pp 379-409.
111. Reh TA, Nagy T, Gretton H. Retinal pigment epithelial cells induced to transdifferentiate to neurons by laminin. Nature 330: 68-71,1987.
112. Song M-K, Lui GM. Propagation of fetal human RPE cells : preservation of original culture morphology after serial passage. J Cell Physiol 143: 196-203,1990.
113. Del Priore LV, Kaplan HJ, Silverman MS, et al. Experimental and surgical aspects of retinal pigment epithelial cell transplantation. Eur J Implant Ref Surg 5: 128-132, 1993
114. Kaplan H. Submacular surgery for choroidal neovascularization (Commentary). Br J Ophthalmol 80: 101,1996.
115. Silverman MS, Hughes SE. Transplantation of photoreceptors to light-damaged retina. Invest Ophthalmol Sci 30: 1684-1690,1989.
116. Bennet SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhages. Am J Ophthalmol 109: 33-37, 1990.
117. Wade EC, Flynn HW, Olsen KR, et al. Subretinal hemorrhage management by pars plana vitrectomy and internal drainage. Arch Ophthalmol 108: 973-978, 1990.
118. Williams DF, Thomas MA. Vitrectomy for removal of submacular hemorrhage. In: Ryans SJ (editor-in-chief) Retina Vol 3, 2nd Ed. St. Louis, Mosby, 1994, pp 2557-2559.
119. El Baba F, Jarrett WH, Harbin TS, et al. Massive hemorrhage complicating age-related macular degeneration. Ophthalmology 93: 1581-1592, 1986.
120. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 94: 762-763, 1982.
121. Koshibu A Ultrastructural studies on absorption of experimentally produced subretinal hemorrhage : III. Absorption of erythrocyte breakdown products and retinal hemosiderosis at the late stage. Nippon Ganka Gakki Zasshi 83: 386-400, 1979.
122. Toth CA, Morse LS, Hjelmeland LM, Landers MB Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol 109: 1731-1734, 1991.
123. Lewis H, Resnick SC, Flannery JG, Straatsma BR. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol 111: 197-204, 1991.
124. Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina 11: 250-258, 1991.
125. Benner JD, Morse LS, Toth CA, et al. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation of the subretinal space of the cat. Arch Ophthalmol 109: 723-729, 1991.
126. Coll GE, Sparrow JR, Marinovic A, Chang S. Effects of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage. Retina 319-326, 1995.
127. Lim JI. Subretinal hemorrhage. Int Ophthalmol Clin 1995, 35: 95-104
128. Gillies A, Lahav M. Absorption of retinal and subretinal hemorrhages. Ann Ophthalmol 15: 1068-1074, 1983.
129. Fekrat S, Avery RL, MacCumber M, Bressler NM. Natural history of subretinal hemorrhage in age related macular degeneration (AMD). Invest Ophthalmol Vis Sci 34 (suppl) : 1133, 1993.
130. Dellaporta A.Retinal damage from subretinal hemorrhage (letter) Am J Ophthalmol 95:568-570,1983.
131. Hanscom TA, Diddie KR. Early surgical drainage of macular subretinal hemorrhage. Arch Ophthalmol 105: 1722-1723, 1987.
132. Slusher MM. Evacuation of submacular hemorrhage : technique and timing. in: Morris R (ed) Vitreoretinal surgery and technology, Vol 1. Thorofare, NJ, Slack Inc, 1989, pp 2,3,8.
133. Kimura AE, Reddy CV, Folk JC, Farmer SG. Removal of subretinal hemorrhage facilitated by preoperative intravitreal tissue plasminogen activator. Retina 14: 83-84,1994.
134. Vander JF, Federman JL, Greven CL, et al. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology 98: 23-27, 1991.
135. Peyman GA, Nelson NC Jr, Alturki W, et al. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg 22:575-578,1991.
136. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 118: 559-568, 1994.
137. Lim JI, Drews-Botsch C, Sternberg P, Jr, et al. Submacular hemorrhage removal. Ophthalmology 102: 1393-1399, 1995.
138. Ibanez HE, Williams DA, Thomas MA, et al. Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol 113; 62-69, 1995.
139. Kamei M, Tano Y, Maeno T, et al. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 121:267-275,1996.
140. Russell SR, Crapotta JA, Zerbolio DJ. Surgical removal of subfoveal neovascularization (letter). Ophthalmology 100: 795-796, 1993.
141. Schachat AP. Should we recommend vitreous surgery for patients with choroidal neovascularization (editorial) Arch Ophthalmol 112: 459-461, 1994.
142. Capone A, Jr, Sternberg P, Jr. Advances in submacular surgery (editorial). Am J Ophthalmol 118: 659-663,1994.
143. Bressler NM. Submacular surgery. Are randomized trials necessary ? Arch Ophthalmol 113. 1557-1560, 1995.
144. Submacular Surgery Trials Manual of Procedure, September 1995.